Wildlife management and radar detection.These are brought together under APHA Scientific to ensure the products and services are delivered effectively to customers. To enhance its scientific activity APHA develops commercial products and services and makes them available to organisations globally. APHA has achieved world reference laboratory status for a number of animal diseases. We specialise in diseases of livestock and plants, diagnosis of disease and surveillance of new and emerging disease. We are currently funded through several intramural mechanisms, extramural grants, and industry partnerships.ĪPHA Scientific Website: Animal and Plant Health Agency (APHA) are an internationally recognised centre of scientific excellence providing a wide range of research and consultancy to the UK Government and commercial customers. Our standard toolkit combines field work with classical microbiology, microscopy, quantitative PCR, high-throughput 16S rRNA sequencing, metagenomics, and associated bioinformatics. Most of the current focus of my research is on the poultry microbiome and its relationships to food safety, infectious disease, and poultry nutrition. Four years as a research microbiologist with the USDA Agricultural Research Service gave me first-hand knowledge of the poultry industry and a chance to apply the tools and techniques of microbial ecology to veterinary microbiology. My graduate training combined classical and microbial ecology but I only considered myself a microbiologist after working in the Microbiology Department of the University of Washington, the Fred Hutchinson Cancer Research Center, and the University of Warwick. Microbial ecology cuts across many fields and I have applied the tools and techniques of microbial ecology to disciplines ranging from oceanography to human and animal health. The revolution in high-throughput DNA sequencing has conclusively demonstrated the importance of microbial communities for life on earth. I am a microbial ecologist interested in tackling important problems at the interface of basic and applied research. Our goal is to support smart interactions between business and academia to enable participants to capitalize on the growing global animal microbiome market. However, these commercial rewards can only be realised by steering through tough legal and regulatory obstacles smartly. Consequently, significant profits can be created by overcoming the obstacles in reproducing animal microbiome research in industry and quicker returns can be obtained by translating the more advanced human microbiome technology to modulate the animal microbiome. The global market is forecasted to grow to $9,775 million by 2028 due to demand for innovation from the rapidly growing meat and pet-healthcare industries.Ĭurrent research strongly indicates that animal microbiome modulation could greatly improve pet health and increase the meat industry’s productivity, while ensuring that it meets its sustainability targets. Animal Microbiome Congress will provide the latest clinical data and key content on the commercialisation of animal microbiome research.
0 kommentar(er)
